Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
888.00    2.00 (0.23%)
Bid:
886.00
Ask:
888.00
Spread: 2.00 (0.226%)
Market Cap: £836.02m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Issue of Equity

31 Mar 2016 09:28

RNS Number : 6840T
Polar Capital Holdings PLC
31 March 2016
 

31 March 2016

Polar Capital Holdings plc

Issue of Equity

Polar Capital Holdings plc ("Polar Capital" or the "Company") announces that today 417,088 ordinary shares of 2.5 pence each in the Company have been allotted and issued in respect of the previously announced (30 September 2013) crystallization of the European Conviction Fund. Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 5 April 2016.

 

This issue is the fourth and final allotment of shares in respect of the European Conviction Fund.

 

The Company's current issued share capital is 90,798,923 ordinary shares and following admission of the New Shares, the total number of ordinary shares allotted and in issue will be 91,216,011.

 

Background

As set out at the time of the Company's admission to AIM, Polar Capital has structured its fund management operations in such a way that the fund management teams are placed in separate business units. Each business unit is a separate profit centre and the fund managers responsible receive an annual payment which comprises a share of their unit's core operating profit (operating profit before performance fees and related distributions) and performance fees.

 

In addition each fund management team is offered the prospect of an interest in the capital of the Company through the purchase of an individual class of preference shares in Polar Capital Partners Limited, a wholly owned subsidiary of the Company. These preference shares have been structured in such a way as to become convertible upon the occurrence of certain events know as crystallisation events into cash or, at the option of the Company, ordinary shares in the Company at a ratio that is intended to be earnings enhancing for the Group.

 

Upon the occurrence of a crystallisation event the fund managers concerned cease to be eligible to receive their share of the business unit's core operating profit and simultaneously going forward receive a reduced interest in their performance fees.

Enquiries:

Polar Capital Holdings

Canaccord Genuity - Nomad and Joint Broker

Tim Woolley (CEO)

Roger Lambert

John Mansell (CFO)

Simon Bridges

Kit Stephenson

Tel: +44 (0)20 7227 2700

+44 (0)20 7523 8350

Peel Hunt - Joint Broker

Guy Wiehahn

Tel: +44 (0)20 7418 8893

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELIFFTVDILVIR
Date   Source Headline
7th Apr 20255:17 pmRNSHolding(s) in Company
26th Mar 20251:01 pmRNSHolding(s) in Company
25th Mar 20258:32 amRNSDirector/PDMR Shareholding
4th Mar 20259:44 amRNSHolding(s) in Company
3rd Feb 20253:34 pmRNSBlock listing Interim Review
28th Jan 20259:33 amRNSDirector/PDMR Shareholding
22nd Jan 20252:05 pmRNSHolding(s) in Company
22nd Jan 20251:44 pmRNSDirector/PDMR Shareholding
17th Jan 202511:07 amRNSDirector/PDMR Shareholding
16th Jan 20252:43 pmRNSForm 8.3 - Direct Line Insurance Group PLC
15th Jan 20252:24 pmRNSForm 8.3 - Direct Line Insurance Group PLC
14th Jan 20254:28 pmRNSForm 8.3 - Direct Line Group PLC
13th Jan 20257:00 amRNSAuM Update
24th Dec 202410:36 amRNSForm 8.3 - Direct Line Insurance Group PLC
23rd Dec 20245:11 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC Amend
23rd Dec 202412:20 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC
2nd Dec 202411:43 amRNSTotal Voting Rights
29th Nov 20244:54 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Nov 202410:02 amRNSHolding(s) in Company
18th Nov 20247:00 amRNSUnaudited Interim Results
12th Nov 20249:14 amRNSCrystallisation of Business Unit & Issue of Shares
31st Oct 20247:00 amRNSNotice of Results
10th Oct 20247:00 amRNSAuM Update
26th Sep 20243:54 pmRNSReplacement: Result of AGM
25th Sep 20243:43 pmRNSResult of AGM
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
5th Aug 20241:44 pmRNSBlock listing Interim Review
1st Aug 20249:16 amRNSDirector/PDMR Shareholding
22nd Jul 20244:53 pmRNSDirector/PDMR Shareholding
18th Jul 20244:56 pmRNSHolding(s) in Company
15th Jul 202411:04 amRNSDirector/PDMR Shareholding
11th Jul 20249:49 amRNSForm 8.3 - CREST NICHOLSON HOLDINGS PLC
11th Jul 20247:00 amRNSAuM Update
4th Jul 20246:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20245:05 pmRNSHolding(s) in Company
27th Jun 20241:15 pmRNSGroup Audited Results for year ended 31 March 2024
27th Jun 20247:00 amRNSGroup Audited Results for year ended 31 March 2024
17th Jun 20243:37 pmRNSForm 8.3 - CREST NICHOLSON HOLDINGS
3rd Jun 20246:16 pmRNSTotal Voting Rights
3rd Jun 20241:56 pmRNSTotal Voting Rights
22nd May 20249:12 amRNSIssue of Equity
15th May 202410:06 amRNSDirector/PDMR Shareholding
13th May 20245:49 pmRNSHolding(s) in Company
13th May 20243:34 pmRNSHolding(s) in Company
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.